We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
88 hedge funds and large institutions have $115M invested in Corvus Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
145% more call options, than puts
Call options by funds: $4.72M | Put options by funds: $1.93M
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
13% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 23
4% more funds holding
Funds holding: 85 → 88 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.47% less ownership
Funds ownership: 58.72% → 53.26% (-5.5%)
43% less capital invested
Capital invested by funds: $202M → $115M (-$86.5M)
Holders
88
Holders Change
+3
Holders Change %
+3.53%
% of All Funds
1.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
26
Reduced
23
Closed
13
Calls
$4.72M
Puts
$1.93M
Net Calls
+$2.79M
Net Calls Change
-$2.56M
Top Buyers
| 1 |
Millennium Management
New York
|
+$6.98M |
| 2 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$1.88M |
| 3 |
Two Sigma Investments
New York
|
+$1.31M |
| 4 |
Morgan Stanley
New York
|
+$1.3M |
| 5 |
Two Sigma Advisers
New York
|
+$1.03M |
Top Sellers
| 1 |
SC
Samlyn Capital
New York
|
-$12.3M |
| 2 |
DM
Deerfield Management
New York
|
-$5.35M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.39M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.14M |
| 5 |
Goldman Sachs
New York
|
-$1.02M |
